First statewide meningococcal B vaccine program in infants, children and adolescents: evidence for implementation in South Australia


Serogroups B, C, W and Y cause most IMD cases in Australia. The highest incidence occurs in children under 5 years of age. A second peak occurs in adolescents and young adults, which is also the age of highest carriage prevalence of N. meningitidis. Program evaluation of vaccine effectiveness against IMD is important. 


Helen S Marshall, Noel Lally, Louise Flood, Paddy Phillips

Learning Outcomes

  • Explain key components of the review.
  • List main recommendations.
  • Recognise changes in management as a result of the review.

Medical Journal of Australia
Reading: journal; textbook; book; literature review
1h : 0m
MBA: 1h : 0m
Infectious Diseases
Medical Practitioner, Medical Student, Doctor-in-Training, Non-Vocationally Registered, Pharmacist, Researcher, Retired, Specialist - Other, Specialist General Practitioner
You have to be logged in to see the content of this module.

Provided by